MRX-800: A Long-Term Safety Study of Maralixibat in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study
Clinical trial NCT04168385 · COMPLETED
Trial details
- NCT number
- NCT04168385
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-16
- Primary completion
- 2024-09-04
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.